Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Focused Fund median (28 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 31 Oct 2014 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | 360 ONE Focused Fund |
|---|---|
| 31 Oct 2014 | ₹100.00 |
| 25 Oct 2015 | ₹106.58 |
| 19 Oct 2016 | ₹128.14 |
| 13 Oct 2017 | ₹145.78 |
| 07 Oct 2018 | ₹134.41 |
| 01 Oct 2019 | ₹166.10 |
| 25 Sep 2020 | ₹175.76 |
| 19 Sep 2021 | ₹296.92 |
| 13 Sep 2022 | ₹301.96 |
| 07 Sep 2023 | ₹355.31 |
| 01 Sep 2024 | ₹489.76 |
| 26 Aug 2025 | ₹453.41 |
| 20 Aug 2026 | ₹485.87 |
| Metric | 360 One · Regular NAV ₹49.21 Very High risk ★★★☆☆ | Category median Focused Fund · 28 funds |
|---|---|---|
| +5.65% | +4.64% | |
| +12.89% | +13.50% | |
| +11.97% | +12.05% | |
| +14.78% | +12.45% | |
| +14.33% | +13.47% | |
| +11.43% | — | |
| +16.52% | +15.62% | |
| +17.20% | +15.47% | |
| +15.69% | +13.06% | |
| Risk | ||
| 15.04% | 14.54% | |
| 0.42 | 0.47 | |
| 0.57 | 0.65 | |
| -36.65% | -34.91% | |
| Nifty 500 | — | |
| +0.66% | +1.70% | |
| 0.91 | 0.94 | |
| 97.0% | 100.9% | |
| 93.1% | 92.7% | |
| 2.16% | 2.21% | |
| ₹6,544Cr | ₹2,441Cr | |
| None | — | |
| None | — | |
| ₹1.00K | — | |
| ₹1.00K | — | |
| 17% | 32% | |
| Ashish Ongari | — | |
| 31 Oct 2014 | — | |
| 29 | — | |
| 53.3% | — | |
| 4.3% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.